WS #13299
Holding: newest synthesis is 100d 15h old
AstraZeneca explores ~$400B acquisition of Bristol Myers Squibb, a major pharma consolidation signal (ongoing from previous cycle, no new data).
Pharma mega-merger exploration
AstraZeneca explores ~$400B acquisition of Bristol Myers Squibb, a major pharma consolidation signal (ongoing from previous cycle, no new data).